Considering that Chicago isn’t exactly a breeding ground for biopharma, Exicure Inc. already had defied expectations by raising more than $42 million since its inception in 2011 as Aurasense Therapeutics LLC and attracting the attention of tech and business notables such as Microsoft Corp. co-founder and philanthropist Bill Gates.